Copyright: ©Author(s) 2026.
World J Gastroenterol. Aug 7, 2026; 32(29): 119809
Published online Aug 7, 2026. doi: 10.3748/wjg.119809
Published online Aug 7, 2026. doi: 10.3748/wjg.119809
Figure 3 Progression-free survival receiver operating characteristic curve.
A: 18-month training and validation set; B: 24-month training and validation set; C: 36-month training and validation set; D: Concordance index over time.
- Citation: Zhou DX, Jiang SW, Zhang CG, Cai BJ, Lv HD. Perioperative SOX plus sintilimab vs P-SOX and CAPOX in advanced gastric cancer: A real-world comparison. World J Gastroenterol 2026; 32(29): 119809
- URL: https://www.wjgnet.com/1007-9327/full/v32/i29/119809.htm
- DOI: https://dx.doi.org/10.3748/wjg.119809